VCP Director Professor Heidi Larson and VCP team members Dr Alexandre de Figueiredo, Caitlin Jarrett and Rachel
Eagan authored an expert report for the UK Covid-19 Public Inquiry on vaccine hesitancy and confidence during the Covid-19 pandemic.

VCP Director Professor Heidi Larson and VCP team members Dr Alexandre de Figueiredo, Caitlin Jarrett and Rachel
Eagan authored an expert report for the UK Covid-19 Public Inquiry on vaccine hesitancy and confidence during the Covid-19 pandemic.
This series of studies highlights the importance of adopting constructive approaches to restoring public health confidence in vaccination, particularly mRNA vaccines.
Professor Heidi Larson spoke to The i Paper about the role of the Covid pandemic in driving vaccine confidence declines among 18 to 24-year-olds: “It was not specifically a reaction to the vaccine. They felt that their education was disrupted, social life restricted and jobs lost or disrupted.”
Vaccine confidence remains a global public health challenge, especially highlighted during the COVID-19 pandemic. This study aims to expand the scope of HCPs’ vaccine confidence oversight into European regions where limited research has been conducted thus far.
Watch part one of the Global Health Cast’s new series on COVID-19, presented by Prof. Joe Schmitt, Prof. Catherine Weil-Olivier, and the VCP’s very own Dr Emilie Karafillakis.
This article reflects on recent research examining the levels and trends of vaccine confidence over time and across the globe, the drivers influencing confidence, and the role of the COVID-19 pandemic in shaping confidence today.
Professor Heidi J. Larson speaks to Science about the potential of COVID-19 vaccine mandates to undermine trust in future public health efforts.
In this VACCELERATE webinar, Heidi Larson will present the key findings of the State of Vaccine Confidence in the EU report, 2022.
LNCT is a platform dedicated to supporting countries as they transition away from Gavi support to full domestic financing of their national immunisation programs.